Respiratory News and Research

RSS

Cancer contributes to schizophrenia mortality

Study findings confirm the increased risk of death from physical diseases among patients with schizophrenia, and reveal cancer mortality as an issue among middle-aged patients.

4 Mar 2014

Covidien's Puritan Bennett 980 ventilator receives CE Mark approval

Covidien plc, a leading global provider of healthcare products and recognized innovator in patient monitoring and respiratory care devices, today announced its Puritan Bennett 980 ventilator has received European Economic Area CE Mark approval.

3 Mar 2014

New article explores risks associated with using herbal cannabis for rheumatic conditions

Patients with rheumatic conditions are in need of symptom relief and some are turning to herbal cannabis as a treatment option. However, the effectiveness and safety of medical marijuana to treat symptoms of rheumatic conditions such as rheumatoid arthritis, lupus, or fibromyalgia is not supported by medical evidence. A new article published in Arthritis Care & Research, a journal of the American College of Rheumatology, explores the risks associated with using herbal cannabis for medicinal purposes and advises healthcare providers to discourage rheumatology patients from using this drug as therapy.

3 Mar 2014

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Atopix Therapeutics Ltd ("Atopix"), a biopharmaceutical company developing innovative CRTH2 antagonists for allergic disease, announced the results of a Phase IIb asthma study with their lead compound OC459 at the American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting , San Diego, California, USA on March 1st.

3 Mar 2014

Scientists map key elements of immune overreaction triggered by influenza virus infection

Scientists at The Scripps Research Institute (TSRI) have mapped key elements of a severe immune overreaction—a "cytokine storm"—that can both sicken and kill patients who are infected with certain strains of flu virus.

3 Mar 2014

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

3 Mar 2014

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

Boehringer Ingelheim today announced new data from large scale, Phase III studies showing that once-daily tiotropium delivered via the Respimat® inhaler was effective and well tolerated in patients across asthma severities.

3 Mar 2014

High-carbohydrate, high-calorie diet could delay progression of Amyotrophic Lateral Sclerosis

A high-carbohydrate, high-calorie diet could delay the progression of Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease or Lou Gehrig’s disease, according to a phase 2 study published in The Lancet.

3 Mar 2014

TSRI scientists describe severe immune overreaction caused by flu infections

Scientists at The Scripps Research Institute have mapped key elements of a severe immune overreaction—a “cytokine storm”—that can both sicken and kill patients who are infected with certain strains of flu virus.

28 Feb 2014

Study: Rising prices is the best way to tackle tobacco-related diseases

A recent study finds that rising prices is, by far, the best way to tackle tobacco-related diseases while ignoring tobacco industry arguments that higher taxes would affect state revenues.

28 Feb 2014

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

An estimated three-quarters of camels recently surveyed in Saudi Arabia have evidence of infection with the Middle East Respiratory Syndrome coronavirus (MERS-CoV), the virus responsible for human cases of MERS.

27 Feb 2014

Walgreens at UCSF aims to improve medication use, reduce hospital readmissions

UC San Francisco and Walgreens have opened a unique Walgreens store today on the UCSF campus that aims to improve medication safety, decrease health care costs and help patients use medicines more effectively by offering pharmacist-based patient care and expanded health and wellness services to the community.

27 Feb 2014

Dampening immune response may encourage lung transplant rejection

Organ transplant patients routinely receive drugs that stop their immune systems from attacking newly implanted hearts, livers, kidneys or lungs, which the body sees as foreign.

27 Feb 2014

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

Prothelia Incorporated (Prothelia) and University of Nevada, Reno announce that they have entered into strategic agreements with Alexion for the development of Laminin-111, a patented experimental protein replacement therapy for merosin-deficient congenital muscular dystrophy (MDC1A), a life-threatening, ultra-rare disease caused by a genetic deficiency of the Laminin-211 protein.

26 Feb 2014

FDA approves KALYDECO for people with cystic fibrosis

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the U.S. Food and Drug Administration (FDA) approved a supplemental New Drug Application (sNDA) for KALYDECOTM (ivacaftor) for people with cystic fibrosis (CF) ages 6 and older who have one of eight additional mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene. KALYDECO was first approved in January 2012 for people with CF ages 6 and older who have at least one copy of the G551D mutation.

26 Feb 2014

Researchers identify polio-like syndrome in cluster of children from California

Researchers have identified a polio-like syndrome in a cluster of children from California over a one-year period, according to a case report released today that will be presented at the American Academy of Neurology's 66th Annual Meeting in Philadelphia, April 26 to May 3, 2014.

25 Feb 2014

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Isis Pharmaceuticals, Inc. today provided an update on its ongoing open label, multiple dose Phase 2 study of ISIS-SMNRx in infants with spinal muscular atrophy (SMA).

25 Feb 2014

Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

The coronavirus responsible for Middle East Respiratory Syndrome (MERS) is prevalent in camels throughout Saudi Arabia and has been around for at least 20 years, according to a study to be published on February 25 in mBio-, the online open-access journal of the American Society for Microbiology.

25 Feb 2014

EarlySense partners with Welch Allyn to increase point of care

EarlySense, the market leader in proactive patient care solutions, together with Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, announced today an ongoing strategic partnership.

25 Feb 2014

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Pfizer Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) to update the current label of XELJANZ® (tofacitinib citrate) 5 mg tablets to include radiographic data from two Phase 3 studies, ORAL Scan (A3921044) and ORAL Start.

25 Feb 2014

Respiratory News and Research

Cancer contributes to schizophrenia mortality

Covidien's Puritan Bennett 980 ventilator receives CE Mark approval

New article explores risks associated with using herbal cannabis for rheumatic conditions

Atopix presents positive results of Phase IIb asthma study at AAAAI meeting

Scientists map key elements of immune overreaction triggered by influenza virus infection

Study explores risks associated with using herbal cannabis for treatment of rheumatic conditions

Phase III studies show tiotropium delivered via Respimat inhaler proves effective in asthma patients

High-carbohydrate, high-calorie diet could delay progression of Amyotrophic Lateral Sclerosis

TSRI scientists describe severe immune overreaction caused by flu infections

Study: Rising prices is the best way to tackle tobacco-related diseases

Study: Direct camel-to-human transmission of MERS virus is possible in Saudi Arabia

Walgreens at UCSF aims to improve medication use, reduce hospital readmissions

Dampening immune response may encourage lung transplant rejection

Prothelia and University of Nevada, Reno enter into agreements with Alexion for development of Laminin-111

FDA approves KALYDECO for people with cystic fibrosis

Researchers identify polio-like syndrome in cluster of children from California

Isis Pharmaceuticals provides update on ISIS-SMNRx Phase 2 study in infants with SMA

Coronavirus responsible for MERS is prevalent in camels throughout Saudi Arabia

EarlySense partners with Welch Allyn to increase point of care

FDA approves sNDA to include radiographic data updating label of Pfizer XELJANZ for treatment of RA

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News